MDM2 and cancer: Increased levels of MDM2, through mechanisms such as gene amplification, increased transcription and elevated translation has been observed in several human cancers [6–8], and MDM2 overexpression has been suggested to be an alternative mechanism of p53 inactivation and tumor promotion [8, 9].